NCT04165330: Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 56 planned
- Started
- 17 Oct 2019
- Primary completion
- 31 Dec 2027
- Arms
- AL3818 plus nivolumab
- Results
- None posted
- 17 Oct 2019: Trial started
- 15 Nov 2019: Trial registered